Centers for Medicare & Medicaid Services CMS issued fact sheet, initial guidance documents on Medicare Prescription Drug Inflation Rebate Program for Medicare Parts B and D, critical component of sweeping prescription drug pricing changes from Inflation Reduction Act of 2022
On February 9, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued a fact sheet and its initial guidance documents addressing the Medicare Prescription Drug Inflation.